Statera BioPharma (STU:7CB) Net Change in Cash : €-12.27 Mil (TTM As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Statera BioPharma's Net Change in Cash for the three months ended in Sep. 2022 was €-0.05 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2022 was €-12.27 Mil.

Statera BioPharma Net Change in Cash Historical Data

The historical data trend for Statera BioPharma's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Net Change in Cash Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Net Change in Cash

-0.01

0.49

5.53

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Net Change in Cash	Get a 7-Day Free Trial						-1.28	-6.52	-6.08	0.38	-0.05

Statera BioPharma Net Change in Cash Calculation

Statera BioPharma's Net Change in Cash for the fiscal year that ended in Dec. 2021 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-24.951	+	11.915	+	18.574	+	-0.006
	=	5.53

Statera BioPharma's Net Change in Cash for the quarter that ended in Sep. 2022

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.81 + 0 + 0.719 + 0.042

= -0.05

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Statera BioPharma's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Net Change in Cash

Comparable Companies

NRBO PALI BLCM MLCT INM YMTX NLSP LEXX ADTX BRTX OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines